What is MLTX's current stock price?

As of now, MLTX is trading at $16.29, with a daily change of -6.61%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

MLTX Stock Analysis & IQ Rating | MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeuti

$16.29

-$1.12 | -6.61%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$62.75

MKT CAP

$1.17B

52W Low

$5.95

VOL

$2.49M

P/E Ratio

N/A

AVG VOL

$2.98M

RSI

58.98

TREND

Uptrend

MLTX Stock IQ

Login to see MoonLake Immunotherapeuti (MLTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

MLTX Target Price

Login to display

Strengths

MLTX Rewards

Earnings are forecast to grow

MLTX Price Performance

$13.95 (+16.77%)

$9.36 (+74.04%)

$55.89 (-70.85%)

$45.99 (-64.58%)

1year

6month

3month

1month

MLTX Risk Level

MLTX has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

MLTX Analysts Opinion

MLTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

MLTX Analysts Opinion

MLTX Analysts opinion is positive and also has improved from the past 3 months

MLTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

80%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

75%

100%

MLTX Street Sentiment

MLTX Street Sentiment is extremely bullish and have positive views on the near-term outlook

MLTX Performance Sentiment

Sentiments overview associated with MLTX events and the stock performance.

80%

10%

Positive

Negative

8 out of 10
events present

1 out of 10
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$17.41

Resistance
Price

$11.17

Current Price Range

$26.08

Show methods +

Linked to MLTX

IQ

Close Price

Change

MRK

4.24

110.93

+0.32%

SNY

3.94

47.38

-1.01%

LLY

4.21

1031.13

-4.06%

INSM

4.11

159.50

-2.40%

IFRX

3.65

1.01

-5.14%

Recently Viewed

Close Price

Change

MLTX

MoonLake Immunotherapeuti

16.29

-6.61%

CGC

Canopy Growth

1.22

0.00%

KMX

CarMax

48.40

+3.45%

CNQ

Canadian Natural Resource

34.04

-2.01%

VICR

Vicor Corporation Co

145.86

+0.33%

MLTX Latest Analysis +

MoonLake cut to sell at Goldman Sachs on risks to lead assets approval.

Today

$16.29 | -6.61%

Rating

BTIG Upgrades MoonLake Immunotherapeutics (MLTX). Fintel reports that on January 9 2026 BTIG upgraded their outlook for MoonLake Immunotherapeutics (NasdaqCM:MLTX) from Neutral to Buy. Analyst Price Forecast Suggests 34.04% Upside

Fri Jan 9, 2026

$18.49 | +28.94%

Potential

Rating

MoonLake Options Trading: A Deep Dive into Market Sentiment. Financial giants have made a conspicuous ish move on MoonLake. Our analysis of options history for MoonLake (NASDAQ:) revealed 20 unusual trades.Delving into the details we found 50% of traders were ish while 30% showed bearish tendencies. Out of all the trades we spotted 2 were puts with a value of $68040 and 18 were calls valued at $814168.After evaluating the trading volumes and Open Interest it'.s evident that the major market

Fri Jan 9, 2026

$18.49 | +28.94%

Momentum

MoonLake: Positive FDA Meeting Spurs Momentum Ahead Of BLA Submission.

Fri Jan 9, 2026

$18.49 | +28.94%

Momentum

MoonLake Says FDA May Allow Skin Drug Filing Without New Trials Stock Soars. ) on Thursday received United States Food and Drug Administration (FDA) feedback regarding the clinical evidence strategy for Sonelokimab (SLK) in (HS) based on the Type B meeting requested by MoonLake.SLK was associated with significant improvements across different key outcomes in over 1000 patients with HS enrolled in the MIRA VELA-1 .MIRA trial data demonstrated a 43% response with 120mg SLK and a 29 ppt delta vs p

Thu Jan 8, 2026

$14.34 | +27.02%

Momentum

MoonLake Catapults On FDA Deal For Its Down-And-Out Skin Disease Drug. Shares of MoonLake Immunotherapeutics catapulted Thursday after potentially aligning with the FDA on a path forward for its skin disease drug.The post MoonLake Catapults On FDA Deal For Its Down-And-Out Skin Disease Drug appeared first on Investor'.s Business Daily.

Thu Jan 8, 2026

$14.34 | +27.02%

Activity

MoonLake surges as no additional studies are required for lead drug.

Thu Jan 8, 2026

$14.34 | +27.02%

Momentum

MoonLake Immunotherapeutics stock price target raised to $45 by Clear Street.

Thu Jan 8, 2026

$14.34 | +27.02%

Potential

FAQ About MLTX Stock Insights

What is MLTX current stock price?

What are MLTX stock strengths?

What is MLTX Risk Level?

What is MLTX market cap and volume?

What is MLTX current Stock IQ?

Should I buy MLTX stock right now?

Is MLTX a Strong Buy right now?

What does a 'Strong Buy' rating mean for MLTX?

What does a 'Strong Sell' rating mean for MLTX?

What factors influence MLTX's Stock IQ?

Explore our MLTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored MLTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our MLTX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

MLTX

MoonLake Immunotherapeuti

Set Alerts

Current Price

$16.29

-$1.12 | -6.61%

52W High

$62.75

MKT CAP

$1.17B

52W Low

$5.95

VOL

$2.49M

P/E Ratio

N/A

AVG VOL

$2.98M

RSI

58.98

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

MLTX Stock IQ

Login to unlock MoonLake Immunotherapeuti (MLTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

MLTX Rewards

Earnings are forecast to grow

Linked to MLTX

Symbol

IQ

Close

Change

MRK

4.24

110.93

+0.32%

SNY

3.94

47.38

-1.01%

LLY

4.21

1031.13

-4.06%

INSM

4.11

159.50

-2.40%

IFRX

3.65

1.01

-5.14%

MLTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

80%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

75%

100%

MLTX Street Sentiment

MLTX Street Sentiment is extremely bullish and have positive views on the near-term outlook

MLTX Risk Level

MLTX has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

MLTX Performance Sentiment

Sentiments overview associated with MLTX events and the stock performance.

80%

10%

Positive

Negative

8 out of 10
events present

1 out of 10
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$17.41

Resistance
Price

$11.17

Current Price Range

$26.08

Show methods +

MLTX Latest Analysis

MoonLake cut to sell at Goldman Sachs on risks to lead assets approval.

Today

$16.29 | -6.61%

Rating

BTIG Upgrades MoonLake Immunotherapeutics (MLTX). Fintel reports that on January 9 2026 BTIG upgraded their outlook for MoonLake Immunotherapeutics (NasdaqCM:MLTX) from Neutral to Buy. Analyst Price Forecast Suggests 34.04% Upside

Fri Jan 9, 2026

$18.49 | +28.94%

Potential

Rating

MoonLake Options Trading: A Deep Dive into Market Sentiment. Financial giants have made a conspicuous ish move on MoonLake. Our analysis of options history for MoonLake (NASDAQ:) revealed 20 unusual trades.Delving into the details we found 50% of traders were ish while 30% showed bearish tendencies. Out of all the trades we spotted 2 were puts with a value of $68040 and 18 were calls valued at $814168.After evaluating the trading volumes and Open Interest it'.s evident that the major market

Fri Jan 9, 2026

$18.49 | +28.94%

Momentum

MoonLake: Positive FDA Meeting Spurs Momentum Ahead Of BLA Submission.

Fri Jan 9, 2026

$18.49 | +28.94%

Momentum

MoonLake Says FDA May Allow Skin Drug Filing Without New Trials Stock Soars. ) on Thursday received United States Food and Drug Administration (FDA) feedback regarding the clinical evidence strategy for Sonelokimab (SLK) in (HS) based on the Type B meeting requested by MoonLake.SLK was associated with significant improvements across different key outcomes in over 1000 patients with HS enrolled in the MIRA VELA-1 .MIRA trial data demonstrated a 43% response with 120mg SLK and a 29 ppt delta vs p

Thu Jan 8, 2026

$14.34 | +27.02%

Momentum

MoonLake Catapults On FDA Deal For Its Down-And-Out Skin Disease Drug. Shares of MoonLake Immunotherapeutics catapulted Thursday after potentially aligning with the FDA on a path forward for its skin disease drug.The post MoonLake Catapults On FDA Deal For Its Down-And-Out Skin Disease Drug appeared first on Investor'.s Business Daily.

Thu Jan 8, 2026

$14.34 | +27.02%

Activity

MoonLake surges as no additional studies are required for lead drug.

Thu Jan 8, 2026

$14.34 | +27.02%

Momentum

MoonLake Immunotherapeutics stock price target raised to $45 by Clear Street.

Thu Jan 8, 2026

$14.34 | +27.02%

Potential

Discover MLTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of MLTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our MLTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

MLTX Stock trends

MLTX Stock performance

MLTX Stock analysis

MLTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MLTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MLTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

MLTX Stock Analysis & IQ Rating | MoonLake Immunotherapeutics

MLTX Stock IQ

MLTX Target Price

MLTX Risk Level

MLTX Analysts Opinion

MLTX Street Sentiment

MLTX Performance Sentiment

Technical Price Levels

Explore our MLTX Stock insights

Receive our MLTX Daily Alerts

MLTX Street Sentiment

MLTX Risk Level

Technical Price Levels

Discover MLTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of MLTX. We're here to help you make informed investment decisions today.

Receive our MLTX Daily Alerts

MLTX Alerts